GSK2818713
| Code | Size | Price |
|---|
| TAR-T38858-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
GSK2818713 is a novel Hepatitis C NS5A replication complex inhibitor.
CAS:
1422484-32-9
Formula:
0
Molecular Weight:
0
Purity:
0.98
SMILES:
0
References
Kazmierski WM, et al. GSK2818713, a Novel Biphenylene Scaffold-Based Hepatitis C NS5A Replication Complex Inhibitor with Broad Genotype Coverage. J Med Chem. 2020 Apr 23;63(8):4155-4170.